| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 22 |
| 1 | ENTECAVIR ANHYDROUS | 14 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 2 |
| 4 | AMLODIPINE | 1 |
| 5 | ARIPIPRAZOLE | 1 |
| 6 | ARIPIPRAZOLE ORAL | 1 |
| 7 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 1 |
| 8 | ATAZANAVIR | 1 |
| 9 | BISOPROLOL FUMARATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENTECAVIR | 22 | 0.0019 |
| 1 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 2 | LAMIVUDINE AND ZIDOVUDINE | 2 | 0.0003 |
| 3 | RALTEGRAVIR | 1 | 0.0002 |
| 4 | RILPIVIRINE | 1 | 0.0001 |
| 5 | QUININE | 1 | 0.0001 |
| 6 | NEVIRAPINE | 1 | 0.0001 |
| 7 | ZIDOVUDINE | 1 | 0.0001 |
| 8 | DIMENHYDRINATE | 1 | 0.0001 |
| 9 | LOPINAVIR AND RITONAVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0004 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 7 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 8 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |